Abstract
Chemical modification of therapeutic peptides is an important approach to improving their physicochemical and pharmacokinetic properties. The triphenylphosphonium (TPP) cation has proved to be a powerful modifier; however, its effects on peptide structure and activity remain uncharacterized. In this study, cytoprotective tetrapeptides based on the YRFK opioid motif with l- or d-Arg residues were linked to (triphenylphosphonio)carboxylic acids with ethylene and pentylene spacers (TPP-3 and TPP-6 groups, respectively). The three-dimensional structure of the oligopeptides was analyzed by NMR spectroscopy, computational methods and circular dichroism (CD). A more compact and bent structure with segregated aromatic groups was revealed for the d-arginine-containing tetrapeptide and its TPP-6 derivative. The TPP moiety caused structure-organizing effect on the tetrapeptides, resulting in transition from random coil to β-sheet structures, and decreased the peptide backbone flexibility up to ten times. The TPP-3-modified oligopeptide with the lowest RMSD value (ca. 0.05 Å) was characterized by intrapeptide hydrophobic interactions between the TPP and side groups of Tyr and Phe residues accompanied by strong CD induction. The TPP-6-modified oligopeptides showed enhanced ability to form intermolecular associates and disturb liposomal membranes. The relationship between the spatial structure of the oligopeptides and some of their biologically relevant interactions were additionally revealed and are discussed.
Similar content being viewed by others
References
Abu-Gosh SE, Kolvazon N, Tirosh B, Ringel I, Yavin E (2009) Multiple triphenylphosphonium cations shuttle a hydrophilic peptide into mitochondria. Mol Pharm 6:1138–1144
Adamska-Bartłomiejczyk A, Borics A, Tömböly C, Dvorácskó S, Lisowski M, Kluczyk A, Wołczański G, Piekielna-Ciesielska J, Janecka A (2017) Synthesis, receptor binding studies, optical spectroscopic and in silico structural characterization of morphiceptin analogs with cis-4-amino-l-proline residues. J Pept Sci 23:864–870
Adessi C, Soto C (2002) Converting a peptide into a drug: strategies to improve stability and bioavailability. Curr Med Chem 9:963–978
Akhmadishina RA, Garifullin R, Petrova NV, Kamalov MI, Abdullin TI (2018) Triphenylphosphonium moiety modulates proteolytic stability and potentiates neuroprotective activity of antioxidant tetrapeptides in vitro. Front Pharmacol 9:115
Andrea G, Andrea C, Paolo R, Gianfranco B (2005) Carnosine and carnosine-related antioxidants: a review. Curr Med Chem 12:2293–2315
Arslan E, Hatip Koc M, Uysal O, Dikecoglu B, Topal AE, Garifullin R, Ozkan AD, Dana A, Hermida-Merino D, Castelletto V, Edwards-Gayle C, Baday S, Hamley I, Tekinay AB, Guler MO (2017) Supramolecular peptide nanofiber morphology affects mechanotransduction of stem cells. Biomacromolecules 18:3114–3130
Asin-Cayuela J, Manas A-RB, James AM, Smith RAJ, Murphy MP (2004) Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant. FEBS Lett 571:9–16
Berger S, Braun S (2004) 200 and more NMR experiments. Wiley, New York
Blokhin DS, Fayzullina AR, Filippov AV, Karataeva FK, Klochkov VV (2015a) Spatial structure of fibrinopeptide B in water solution with DPC micelles by NMR spectroscopy. J Mol Struct 1102:91–94
Blokhin DS, Filippov AV, Antzutkin ON, Afonin S, Klochkov VV (2015b) Spatial structures of PAP(262–270) and PAP(274–284), two selected fragments of PAP(248–286), an enhancer of HIV infectivity. Appl Magn Reson 46:757–769
Dai D-F, Chen T, Szeto H, Nieves-Cintrón M, Kutyavin V, Santana LF, Rabinovitch PS (2011) Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol 58:73–82
Fosgerau K, Hoffmann T (2015) Peptide therapeutics: current status and future directions. Drug Discov Today 20:122–128
Garifullin R, Guler MO (2015) Supramolecular chirality in self-assembled peptide amphiphile nanostructures. Chem Commun 51:12470–12473
Gentilucci L, De Marco R, Cerisoli L (2010) Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Curr Pharm Des 16(28):3185–3203
Hall V, Sklepari M, Rodger A (2014) Protein secondary structure prediction from circular dichroism spectra using a self-organizing map with concentration correction. Chirality 26:471–482
Hamamoto K, Kida Y, Zhang Y, Shimizu T, Kuwano K (2013) Antimicrobial activity and stability to proteolysis of small linear cationic peptides with d-amino acid substitutions. Microbiol Immunol 46:741–749
Khailova LS, Nazarov PA, Sumbatyan NV, Korshunova GA, Rokitskaya TI, Dedukhova VI, Antonenko YN, Skulachev VP (2015) Uncoupling and toxic action of alkyltriphenylphosphonium cations on mitochondria and the bacterium Bacillus subtilis as a function of alkyl chain length. Biochemistry (Moscow) 80:1589–1597
Kononova O, Litvinov RI, Blokhin DS, Klochkov VV, Weisel JW, Bennett JS, Barsegov V (2017) Mechanistic basis for the binding of RGD- and AGDV-peptides to the platelet integrin αIIbβ3. Biochemistry 56:1932–1942
Mangoni ML, Papo N, Saugar JM, Barra D, Shai Y, Simmaco M, Rivas L (2006) Effect of natural l- to d-amino acid conversion on the organization, membrane binding, and biological function of the antimicrobial peptides bombinins H. Biochemistry 45:4266–4276
Mares-Guia M, Shaw E (1965) Studies on the active center of trypsin: the binding of amidines and guanidines as models of the substrate side chain. J Biol Chem 240:1579–1585
Meng H, Kumar K (2007) Antimicrobial activity and protease stability of peptides containing fluorinated amino acids. J Am Chem Soc 129:15615–15622
Murphy MP, Smith RAJ (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47:629–656
Oleksyszyn J, Powers JC (1994) [30] Amino acid and peptide phosphonate derivatives as specific inhibitors of serine peptidases. Methods Enzymol 244:423–441
Olsen JV, Ong S-E, Mann M (2004) Trypsin cleaves exclusively C-terminal to arginine and lysine residues. Mol Cell Proteom 3:608–614
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612
Pugachev MV, Shtyrlin NV, Sysoeva LP, Nikitina EV, Abdullin TI, Iksanova AG, Ilaeva AA, Musin RZ, Berdnikov EA, Shtyrlin YG (2013) Synthesis and antibacterial activity of novel phosphonium salts on the basis of pyridoxine. Bioorg Med Chem 21:4388–4395
Rose GD, Glerasch LM, Smith JA (1985) Turns in peptides and proteins. In: Anfinsen CB, Edsall JT, Richards FM (eds) Advances in protein chemistry, vol 37. Academic Press, New York, pp 1–109
Ross MF, Filipovska A, Smith RAJ, Gait MJ, Murphy MP (2004) Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers. Biochem J 383:457
Rule GS, Hitchens TK (2006) Fundamentals of protein NMR spectroscopy. Springer, The Netherlands
Schrank E, Wagner G, Zangger K (2013) Solution NMR studies on the orientation of membrane-bound peptides and proteins by paramagnetic probes. Molecules 18:7407
Schwieters CD, Kuszewski JJ, Tjandra N, Clore GM (2003) The Xplor-NIH NMR molecular structure determination package. J Magn Reson 160:65–73
Shiba K (2010) Natural and artificial peptide motifs: their origins and the application of motif-programming. Chem Soc Rev 39:117–126
Szeto HH (2006) Cell-permeable, mitochondrial-targeted, peptide antioxidants. AAPS J 8:E277–E283
Szeto HH (2008) Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid Redox Signal 10:601–619
Torres AM, Menz I, Alewood PF, Bansal P, Lahnstein J, Gallagher CH, Kuchel PW (2002) d-Amino acid residue in the C-type natriuretic peptide from the venom of the mammal, Ornithorhynchus anatinus, the Australian platypus. FEBS Lett 524:172–176
Torres AM, Tsampazi M, Tsampazi C, Kennett Eleanor C, Belov K, Geraghty Dominic P, Bansal Paramjit S, Alewood Paul F, Kuchel PW (2006) Mammalian l-to-d-amino-acid-residue isomerase from platypus venom. FEBS Lett 580:1587–1591
Tsepaeva OV, Nemtarev AV, Abdullin TI, Grigor’eva LR, Kuznetsova EV, Akhmadishina RA, Ziganshina LE, Cong HH, Mironov VF (2017) Design, synthesis, and cancer cell growth inhibitory activity of triphenylphosphonium derivatives of the triterpenoid betulin. J Nat Prod 80:2232–2239
Ung P, Winkler DA (2011) Tripeptide motifs in biology: targets for peptidomimetic design. J Med Chem 54:1111–1125
Usachev KS, Filippov AV, Antzutkin ON, Klochkov VV (2013) Use of a combination of the RDC method and NOESY NMR spectroscopy to determine the structure of Alzheimer’s amyloid Aβ10–35 peptide in solution and in SDS micelles. Eur Biophys J 42:803–810
Usachev KS, Efimov SV, Kolosova OA, Klochkova EA, Aganov AV, Klochkov VV (2015) Antimicrobial peptide protegrin-3 adopt an antiparallel dimer in the presence of DPC micelles: a high-resolution NMR study. J Biomol NMR 62:71–79
Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M (2010) Synthetic therapeutic peptides: science and market. Drug Discov Today 15(1–2):40–56
Warschawski DE, Arnold AA, Beaugrand M, Gravel A, Chartrand É, Marcotte I (2011) Choosing membrane mimetics for NMR structural studies of transmembrane proteins. Biochim Biophys Acta (BBA) Biomembr 1808:1957–1974
Wei G-X, Bobek LA (2005) Human salivary mucin MUC7 12-Mer-l and 12-Mer-d peptides: antifungal activity in saliva, enhancement of activity with protease inhibitor cocktail or EDTA, and cytotoxicity to human cells. Antimicrob Agents Chemother 49:2336–2342
Weißhoff H, Präsang C, Henklein P, Frömmel C, Zschunke A, Mügge C (1999) Mimicry of βII′-turns of proteins in cyclic pentapeptides with one and without d-amino acids. Eur J Biochem 259:776–789
Witt KA, Gillespie TJ, Huber JD, Egleton RD, Davis TP (2001) Peptide drug modifications to enhance bioavailability and blood–brain barrier permeability. Peptides 22:2329–2343
Wu L, McElheny D, Huang R, Keiderling TA (2009) Role of tryptophan–tryptophan interactions in trpzip β-hairpin formation, structure, and stability. Biochemistry 48:10362–10371
Zielonka J, Joseph J, Sikora A, Hardy M, Ouari O, Vasquez-Vivar J, Cheng G, Lopez M, Kalyanaraman B (2017) Mitochondria-targeted triphenylphosphonium-based compounds: syntheses, mechanisms of action, and therapeutic and diagnostic applications. Chem Rev 117:10043–10120
Acknowledgements
This work was performed according to the Russian Government Program of Competitive Growth of the Kazan Federal University. R. G. acknowledges the Russian Foundation for Basic Research (Grant no. 16-33-60146). Dr. T. Mukhametzyanov from Kazan Federal University is acknowledged for his assistance in performing CD measurements. The equipment of Interdisciplinary Centre for Shared Use of Kazan Federal University was used.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Garifullin, R., Blokhin, D.S., Akhmadishina, R.A. et al. Effect of triphenylphosphonium moiety on spatial structure and biointeractions of stereochemical variants of YRFK motif. Eur Biophys J 48, 25–34 (2019). https://doi.org/10.1007/s00249-018-1327-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00249-018-1327-x